Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.
about
Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular CarcinomaRole of MicroRNAs-221/222 in Digestive SystemsRole of microRNAs in hepatocellular carcinoma: a clinical perspectiveGuide for diagnosis and treatment of hepatocellular carcinomaOral squamous cell carcinoma cells are resistant to doxorubicin through upregulation of miR‑221Overexpression of miRNA-221 promotes cell proliferation by targeting the apoptotic protease activating factor-1 and indicates a poor prognosis in ovarian cancer.Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells.Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues.MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214Upregulated MiR-1269 in hepatocellular carcinoma and its clinical significanceAssociation between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissuesMiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1.Down-Regulation of MiR-193a-3p Dictates Deterioration of HCC: A Clinical Real-Time qRT-PCR Study.An Encapsulation of Gene Signatures for Hepatocellular Carcinoma, MicroRNA-132 Predicted Target Genes and the Corresponding OverlapsEffect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKTMicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.Clinicopathological significance of STAT4 in hepatocellular carcinoma and its effect on cell growth and apoptosis.Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinomaClinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis.Downregulation of miR-219 enhances brain-derived neurotrophic factor production in mouse dorsal root ganglia to mediate morphine analgesic tolerance by upregulating CaMKIIγ.Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma.Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic CholangiocarcinomaExpression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues.Role of microRNAs in inflammation-associated liver cancerPotential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases.Strategy for chemotherapeutic delivery using a nanosized porous metal-organic framework with a central composite design.The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations.A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma.miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma.Non-Coding RNAs in Primary Liver Cancer.miRNA for diagnosis and clinical implications of human hepatocellular carcinoma.Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review.Mir-221/222 are promising targets for innovative anticancer therapy.Experimental verification of a conserved intronic microRNA located in the human TrkC gene with a cell type-dependent apoptotic function.Endoplasmic reticulum stress in the regulation of liver diseases: Involvement of Regulated IRE1α and β-dependent decay and miRNA.Prognostic role of microRNA-221 in various human malignant neoplasms: a meta-analysis of 20 related studiesCirculating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma.New Insights into the Epigenetics of Hepatocellular Carcinoma.
P2860
Q26782003-7A29D852-6355-460B-B351-01F35AE2B62FQ26799877-B7E14C5B-41FD-4011-9C46-0E11FAAF4045Q27014034-831DF38C-46F2-4EEE-9AD6-2B3E370642E0Q28084003-7BE36BBE-BD3A-4816-A94C-EED4F07942D4Q32174236-AD986BBF-18C9-497E-AAA5-EE6EA019F78CQ32179591-74F1A671-7900-4B5A-90CC-D183A5BE2CBEQ33660974-A8747003-0B7C-40B9-BCE4-4AB79ADEB074Q34645417-F5253E12-9690-440B-AB54-571181929BB6Q35027675-5F8825EB-7EF1-4457-A4BF-CA03BC950DE3Q35173587-B6214422-FD49-48BC-9490-25D303778994Q35776681-29BA5971-F913-4AD1-8F04-F7637FC4DD33Q35925686-57AC8D10-0418-4D2B-9E24-9D87DF40EEE0Q35961790-684EAB86-F7DB-4037-8C7D-71F61E6B269DQ36088484-40A106AE-BCA1-4D3C-B96F-77E42667AB67Q36130960-93F0B9FC-2702-4F81-83A9-098EBEF006E0Q36210961-7469BFB2-9436-45EA-922A-3DB57E6DBE88Q36413124-1408867D-F0CE-4B17-936F-E1F45E7E046FQ36729248-7F5D6280-EDC8-4969-BE38-EEEB75A4E3BFQ36746133-9820BEF6-BD48-4904-B364-4A3DB02C4093Q36884764-7E5D266E-F182-40B4-9CEB-686A9AEB1406Q37187684-79633891-CEF0-4D25-864A-9CABA9B57470Q37238128-58CA3A67-A75A-42C7-A20F-4B0E9A9A2341Q37288584-CDA2B73A-3043-4009-91C2-FD59892D7030Q37296946-37EECBB3-C8DD-41D6-B3D6-5D1D76F4F63DQ37564156-2C47058F-53E5-46F5-B68C-F09BE57F4CFDQ37596666-5EEDF079-3DB4-4DD4-8093-0F32F703DB93Q37643929-6900D121-D0FA-4278-9A03-D7D32C1B9CECQ37670045-6C64537E-99BA-42A4-9B7E-B89D094D28ADQ38178032-7F5D8CCC-18D7-4D0F-BEAE-46A39001457EQ38430715-B5C2F2E0-B850-44E3-9D07-1711AC82B3F7Q38442897-3A663619-6F15-486F-9D6B-8B07424F27E5Q38541359-04C5E2D0-0F26-4715-9E4B-5383D96DB043Q38568853-22F1DF4B-C98F-4935-AA90-5055BFBC6ABFQ38613525-EDA6C662-7464-4FED-A12A-2E0AD2A8D3CBQ38767024-FD965625-CE49-4CB5-94DF-4003305D6D3AQ38899793-9C9F9C69-8E75-42F7-9C4B-4FD2ACEF1F7FQ38989169-697D121C-97F8-49A2-80B3-9C4FCECD36EFQ39261238-A65592A1-8F99-48BA-AB9E-22F4E2C56643Q41921235-9CA9FD5C-6DD4-4AE9-9354-A371059B7842Q41990459-68F1AB30-D3BF-4D87-B435-22B9AAA56828
P2860
Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Increased miR-221 expression i ...... inhibiting apoptosis in vitro.
@ast
Increased miR-221 expression i ...... inhibiting apoptosis in vitro.
@en
Increased miR-221 expression i ...... inhibiting apoptosis in vitro.
@nl
type
label
Increased miR-221 expression i ...... inhibiting apoptosis in vitro.
@ast
Increased miR-221 expression i ...... inhibiting apoptosis in vitro.
@en
Increased miR-221 expression i ...... inhibiting apoptosis in vitro.
@nl
prefLabel
Increased miR-221 expression i ...... inhibiting apoptosis in vitro.
@ast
Increased miR-221 expression i ...... inhibiting apoptosis in vitro.
@en
Increased miR-221 expression i ...... inhibiting apoptosis in vitro.
@nl
P2093
P2860
P356
P1433
P1476
Increased miR-221 expression i ...... inhibiting apoptosis in vitro.
@en
P2093
P2860
P2888
P356
10.1186/1471-2407-13-21
P407
P577
2013-01-16T00:00:00Z
P5875
P6179
1033492085